Internal Medicine, Hematology & Oncology · Hilton Head Island, SC
NPI
1043218316
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
45 Hospital Center Cmns
Hilton Head Island, SC, 29926
Phone (843) 699-2895
Groups this clinician bills Medicare through
Medicare paid, 2024
$295K
4,254 services
Medicare patients, 2024
1,210
Average age 77
Drug cost, 2024
$12.2M
2,372 prescriptions
Company payments, 2025
$5,947
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary W Thomas was code 99214 (office e&m - established), 1,649 times for 610 patients. In total Gary W Thomas billed 4,254 services in 21 codes, and Medicare paid $295K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,649 | 610 | $90.42 | $149K |
| 99213 Office E&M - Established | Office | 1,295 | 764 | $60.73 | $79K |
| 85025 Blood Count | Office | 702 | 271 | $7.61 | $5,342 |
| 99205 Office E&M - New | Office | 195 | 195 | $156.78 | $31K |
| 99215 Office E&M - Established | Office | 181 | 135 | $129.33 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 128 | 104 | $12.27 | $1,571 |
| 99204 Office E&M - New | Office | 20 | 20 | $111.60 | $2,232 |
| 99212 Office E&M - Established | Office | 14 | 13 | $38.80 | $543 |
By year: 2022 $373K for 5,229 services; 2023 $404K for 5,781 services; 2024 $295K for 4,254 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 702 | 271 | $7.61 | $5,342 |
Medicare prescription drug claims, 2024
In 2024, the drug Gary W Thomas prescribed most often to Medicare patients was Anastrozole, with 398 prescriptions and refills. In total Gary W Thomas wrote 2,372 Medicare prescriptions that cost $12.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 398 | 1,126 | 132 | $9,069 |
| Hydroxyurea Generic | 160 | 370 | 43 | $5,432 |
| Acyclovir Generic | 120 | 166 | 27 | $1,710 |
| Prednisone Generic | 106 | 148 | 31 | $681 |
| Letrozole Generic | 97 | 263 | 33 | $1,439 |
| Brukinsa Zanubrutinib | 96 | 96 | 11 | $1.4M |
| Abiraterone Acetate Generic | 90 | 96 | Under 11 | $322K |
| Revlimid Lenalidomide | 80 | 80 | Under 11 | $1.4M |
| Dexamethasone Generic | 79 | 98 | 47 | $1,727 |
| Lenalidomide Generic | 64 | 64 | Under 11 | $947K |
| Calquence Acalabrutinib Maleate | 63 | 63 | Under 11 | $979K |
| Ondansetron Hcl Generic | 55 | 55 | 45 | $467 |
| Jakafi Ruxolitinib Phosphate | 52 | 52 | Under 11 | $930K |
| Oxycodone Hcl Generic | 49 | 49 | 18 | $798 |
| Ondansetron Odt Ondansetron | 48 | 48 | 39 | $682 |
Brand drugs: 661 claims; generic drugs: 1,711 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary W Thomas $5,947 ($5,947 in general payments such as food, travel and fees) from 39 companies. The largest payer was Avyxa Pharma, LLC with $3,389.
| Company | Payments | Amount |
|---|---|---|
| Avyxa Pharma, LLC | 5 | $3,389 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $274 |
| Pfizer Inc. PFE | 9 | $212 |
| Merck Sharp & Dohme LLC MRK | 9 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $187 |
| BeOne Medicines USA, Inc. ONC | 5 | $137 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $93.09 |
| Taiho Oncology, Inc. 4578.T | 3 | $85.38 |
| Daiichi Sankyo Inc. 4568.T | 3 | $83.84 |
| Lilly USA, LLC LLY | 3 | $81.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.